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INTRODUCTION: Diagnostic medial branch blocks (MBB) confirm whether the
origin of lower back pain is the facet joint, but are prone to false positive results. This
study investigates the effects of midazolam sedation on perceived intensity of pain
relief following lumbar MBB and determines the frequency of positive results in
sedated patients for the corresponding treatment, radiofrequency thermocoagulation
(RFTC).
METHODS: This prospective observational study compares pain scores between
patients who undergo the MBB procedure with midazolam sedation (treatment) and
without (control). Participants reported baseline and post-injection NRS pain scores,
and 4, 8 weeks post-RFTC. If >80% pain relief was achieved post-diagnostic block,
but RFTC produced <50% pain relief, the score was considered “false positive.” The
primary outcome was the difference between baseline versus lowest post-injection
score and the frequency of false positive results in sedated RFTC patients.
RESULTS: 27 and 26 patients completed diagnostic MBBs in the non-sedation group
and sedation group, respectively. There was not a significant difference in NRS pain
score change between groups for diagnostic block 1 and 2 (80.77% vs 74.07%,
respectively). There was also not a significant relationship between sedation and nonsedation with false positive RFTCs at week 4 (69.23% vs 61.11%) or at week 8
(70.0% vs 75.0%).
CONCLUSIONS: In summary, this study found no significant difference in NRS pain
scores for patients who were or were not given midazolam sedation for diagnostic
lumbar MBBs. Further, sedation did not significantly impact frequency of positive
RFTC results. Larger studies are required to draw definitive conclusions.

